Russell Investments Group’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
25,209
+4,987
+25% +$500K ﹤0.01% 1980
2026
Q1
$1.36M Sell
20,222
-556
-3% -$41.2K ﹤0.01% 2065
2025
Q4
$1.64M Sell
20,778
-17,356
-46% -$1.18M ﹤0.01% 1980
2025
Q3
$1.28M Buy
38,134
+8,141
+27% +$200K ﹤0.01% 2090
2025
Q2
$428K Buy
29,993
+2,963
+11% +$38.3K ﹤0.01% 2396
2025
Q1
$378K Sell
27,030
-27,315
-50% -$371K ﹤0.01% 2393
2024
Q4
$837K Sell
54,345
-29,766
-35% -$453K ﹤0.01% 2090
2024
Q3
$1.32M Buy
84,111
+13,547
+19% +$190K ﹤0.01% 1902
2024
Q2
$1,000K Buy
+70,564
New +$1.1M ﹤0.01% 1978

Other funds holding INBX

Russell Investments Group's INBX Position: Q2 2026 in Review

Russell Investments Group increased its Inhibrx (INBX) stake by 25% in Q2 2026, buying an estimated $500K and bringing the position to 25,209 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

Russell Investments Group first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 53 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Russell Investments Group held 25,209 shares of Inhibrx worth $2.39M as of Q2 2026.
  • Russell Investments Group bought 4,987 Inhibrx shares in Q2 2026, an estimated $500K.
  • Inhibrx made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1980 holding.
  • Russell Investments Group first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 53 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.